Among these, the identification of genome-wide significant signals at the IL34, ACE and KANSL1 loci—loci that were not significant in the base GWAS but were subsequently identified to be associated with AD in independent studies—shows the validity of this approach. This evidence concerns the gene IL34 and Alzheimer disease.